Latest News

Motilal Oswal is bullish on Star Health recommended buy rating on the stock with a target price of Rs 810 in its research report dated November 10, 2022. Read More Top 100 Best Sellers

â€�It is known for red carpet for investors. Whether it is FDI reforms, or liberalisation of drone rules, or steps in the semiconductor sector, or the production incentive schemes in various sectors, or the rise of ease of doing businessâ€�,… Read More »India using technology as a weapon in war against poverty: PM

Bikaji Foods traded with a volume of 20.96 lakh shares on the BSE and 2.74 crore shares on the National Stock Exchange Read More Top 100 Best Sellers

The IT industry is expected to grow at 8-10 percent on a base of $220 billion, which is not a small growth, Gopalakrishnan has said Top 100 Best Sellers Read More

Motilal Oswal recommended Neutral rating on Deepak Nitrite with a target price of Rs 1890 in its research report dated November 11, 2022. Read More Top 100 Best Sellers

Motilal Oswal recommended Neutral rating on Fine Organics with a target price of Rs 6860 in its research report dated November 12, 2022. Read More Top 100 Best Sellers

Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 680 in its research report dated November 10, 2022. Top 100 Best Sellers Read More

Motilal Oswal recommended Neutral rating on Pidilite Industries with a target price of Rs 2500 in its research report dated November 10, 2022. Top 100 Best Sellers Read More

The rupee declined 0.25% to 81.2975 per dollar. It has shed nearly a percent from its high of 80.51 on Monday, with volatility gripping markets this week. Top 100 Best Sellers Read More

India’s long term decarbonisation strategy is in the right direction despite limitations and distractions Read More Top 100 Best Sellers